Abstract
Urinary tract infections remain the most common bacterial infection in human population. They are also one of the most frequently occurring nosocomial infections, representing about 40% of all nosocomial bacterial infections world widely and associated with important medical and financial implications. This retrospective study aimed to establish the bacterial profile of UTIs in Benin. Therefore, reported data were collected from 2003 to 2012 at Menontin’s Hospital in Cotonou and subjected to analyses. At the end of the study, fourteen different bacteria species were found to be associated with UTI cases in Benin. Escherichia coli was the most prevalent followed by Staphylococcus aureus. Results of the current study are helpful to the health care community of Benin in establishing the appropriate antibiotherapy for UTI patients’ treatment with respect organisms into circulation.
Highlights
Respiratory and urinary tract infections (UTI), are associated with the highest level of morbidity in mankind and are of great public health concern
Profile of Bacteria Isolated from UTI Suspected Patients from 2003 to 2012 at Menontin Hospital
From 2003 to 2012, fourteen different bacteria species were isolated from patients with UTI symptoms, namely: Staphylococcus aureus (25.08%), S. epidermidis (1.88%), S. saprophyticus (0.96%), Streptococcus D (14.24%), Streptococcus B(1.03%), Escherichia coli (36.07), Kleb
Summary
Respiratory and urinary tract infections (UTI), are associated with the highest level of morbidity in mankind and are of great public health concern. Remain the most common bacterial infection in human population and one of the most frequently occurring nosocomial infections, representing about 40% of all nosocomial bacterial infections world widely [1]. Urinary tract infections are major causes of morbidity and mortality in the first 2 years of human life, in women and mostly in elders [3]. Due to this wide variety of causative agents, the treatment of UTIs is sometimes inadequate. Appropriate medication might not be given and this can lead to challenges such as antibiotic resistance among patients. In order to control the emergence of antimicrobial resistance among
Sign-in/Register to view highlights & summary 
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call